{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T18:12:42Z","timestamp":1761675162016},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1983,1,1]],"date-time":"1983-01-01T00:00:00Z","timestamp":410227200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[1983]]},"DOI":"10.1007\/bf01037935","type":"journal-article","created":{"date-parts":[[2005,1,18]],"date-time":"2005-01-18T13:43:32Z","timestamp":1106055812000},"page":"287-292","source":"Crossref","is-referenced-by-count":2,"title":["Effects of prenalterol on cardiac performance and transmural myocardial perfusion in patients with chronic renal failure"],"prefix":"10.1007","volume":"25","author":[{"given":"T.","family":"Pedersen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Cleemann-Rasmussen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Brynjolf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"\ufffdrding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. E.","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Rasmussen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1136\/hrt.42.2.139","volume":"42","author":"R Areniego","year":"1977","unstructured":"Areniego R, Waagstein F, Mombay B, Hjalmarson A (1977) Haemodynamic effects of a new?-receptor agonist in acute myocardial infarction. Br Heart J 42: 139?146","journal-title":"Br Heart J"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0033-8389(22)01298-2","volume":"18","author":"HJ Berger","year":"1980","unstructured":"Berger HJ, Gottschalk A, Zaret BL (1980) Radionuclide assessment of left and right ventricular performance. Radiol Clin North Am 18: 441?466","journal-title":"Radiol Clin North Am"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0140-6736(80)90602-9","volume":"1","author":"T Dr\u00fceke","year":"1980","unstructured":"Dr\u00fceke T, Fauchet M, Fleury J, Lesourd P, Toure Y, Le Pailleur C, de Vernejoul P, Crosnier J (1980) Effect of parathyroidectomy on left-ventricular function in haemodialysis patients. Lancet 1: 112?114","journal-title":"Lancet"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1007\/BF02475543","volume":"11","author":"LA Geddes","year":"1973","unstructured":"Geddes LA, Sadler C (1973) The specific resistance of blood at body temperature. Med Biol Eng 11: 336?339","journal-title":"Med Biol Eng"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1161\/01.CIR.58.3.381","volume":"58","author":"JIE Hoffman","year":"1978","unstructured":"Hoffman JIE (1978) Determinants and prediction of transmural myocardial perfusion. Circulation 58: 381?391","journal-title":"Circulation"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/BF00609978","volume":"13","author":"G Johnsson","year":"1978","unstructured":"Johnsson G, Jord\u00f6 L, Lundborg P, R\u00f6nn O, Welin-Fogelberg I, Wikstrand J (1978) Haemodynamic and tolerance studies in man of a new orally active, selective?-adrenoceptor agonist H 80\/62. Eur J Clin Pharmacol 13: 163?170","journal-title":"Eur J Clin Pharmacol"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/0002-8703(78)90302-2","volume":"95","author":"M Kaus","year":"1978","unstructured":"Kaus M, Paster B, Dubach VC, Imhof PR (1978) Human pharmacology studies with a new orally selective stimulant of cardiac adrenorgic?-receptors. Am Heart J 95: 602?609","journal-title":"Am Heart J"},{"key":"CR8","first-page":"1208","volume":"37","author":"WG Kubicek","year":"1966","unstructured":"Kubicek WG, Karnegis IN, Patterson RP, Witsoe DA, Mattson RH (1966) Development and evaluation of an impedance cardiac output system. Aerosp Med 37: 1208?1212","journal-title":"Aerosp Med"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1399-6576.1980.tb01495.x","volume":"24","author":"S Reiz","year":"1980","unstructured":"Reiz S, Friedman A (1980) Haemodynamic and cardiometabolic effects of prenalterol in patients with gram negative septic shock. Acta Anaesthesiol Scand 24: 5?10","journal-title":"Acta Anaesthesiol Scand"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/BF00562614","volume":"17","author":"O R\u00f6nn","year":"1980","unstructured":"R\u00f6nn O, Pellenius E, Graffner C, Johnsson G, Lundborg P, Svendsson L (1980) Metabolic and haemodynamic effects and pharmacokinetics of a new selective?-adrenoceptor agonist, prenalterol in man. Eur J Clin Pharmacol 17: 81?86","journal-title":"Eur J Clin Pharmacol"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1365-2125.1979.tb00947.x","volume":"7","author":"DHT Scott","year":"1979","unstructured":"Scott DHT, Arthur GR, Boyes RN, Scott EB (1979) Cardiovascular effects of prenalterol (H 133\/22) in normal man. Br J Clin Pharmacol 7: 365?370","journal-title":"Br J Clin Pharmacol"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/BF00563002","volume":"18","author":"IL Svendsen","year":"1980","unstructured":"Svendsen IL, Hartling OJ, Trap-Jensen I (1980) Immediate haemodynamic effects of prenalterol, a new adrenoceptor?-receptor agonist in healthy volunteers. Eur J Clin Pharmacol 18: 219?223","journal-title":"Eur J Clin Pharmacol"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01037935.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01037935\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01037935","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T17:06:28Z","timestamp":1682960788000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01037935"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1983]]},"references-count":12,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1983]]}},"alternative-id":["BF01037935"],"URL":"https:\/\/doi.org\/10.1007\/bf01037935","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[1983]]}}}